Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 1, 2013, Pages 333-344

  Yuferov, Vadim ^a   Ho, Ann ^a   Morgello, Susan ^b   Yang, Yaning ^c   Ott, Jurg ^d   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Chemokine receptors and ligands; Ephrin receptors and ligands; HIV dementia; Human postmortem brain; Neurocognitive impairment

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; EPHRIN; EPHRIN B1; EPHRIN B2; EPHRIN RECEPTOR; EPHRIN RECEPTOR A4; EPHRIN RECEPTOR B2; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA;

ADULT; ANTERIOR CINGULATE; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CD4 LYMPHOCYTE COUNT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AIDS DEMENTIA COMPLEX; BRAIN CHEMISTRY; CAUDATE NUCLEUS; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; GENE EXPRESSION; GYRUS CINGULI; HIV INFECTIONS; HUMANS; LIGANDS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPHA4; RECEPTORS, EPH FAMILY; RNA, MESSENGER; TISSUE BANKS; VIRAL LOAD; YOUNG ADULT;

EID: 84874666206     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9429-1     Document Type: Article

References (46)

1. Attwood BK, Bourgognon JM, Patel S, Mucha M, Schiavon E, Skrzypiec AE et al (2011) Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473:372-375
2. Binder EB (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34(Suppl 1):S186-S195
3. Borjabad A, Morgello S, Chao W, Kim SY, Brooks AI, Murray J et al (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 7:e1002213
4. Bouvier D, Corera AT, Tremblay ME, Riad M, Chagnon M, Murai KK et al (2008) Pre-synaptic and post-synaptic localization of EphA4 and EphB2 in adult mouse forebrain. J Neurochem 106:682-695
5. Bustin SA, Mueller R (2005) Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond) 109:365-379
6. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622
7. Calò L, Cinque C, Patanè M, Schillaci D, Battaglia G, Melchiorri D, Nicoletti F, Bruno V (2006) Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration. J Neurochem 98:1-10
8. Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B et al (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469:47-52
9. Clifford DB (2008) HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 16:94-98
10. Coulson DT, Brockbank S, Quinn JG, Murphy S, Ravid R, Irvine GB, Johnston JA (2008) Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol 9:46
11. Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33-44
12. Erdmann NB, Whitney NP, Zheng J (2006) Potentiation of excitotoxicity in HIV-1 associated dementia and the significance of glutaminase. Clin Neurosci Res 6:315-328
13. Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L (2010) Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging 32:1045-1053
14. Espey MG, Ellis RJ, Heaton RK, Basile AS (1999) Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex. Neurology 53:1144-1145
15. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH et al (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9:209-217
16. Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57:671-675
17. Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Susan Morgello for the National NeuroAIDS Tissue Consortium (2012) The national NeuroAIDS tissue consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 7(9):e46178. doi: 10.1371, Epub 2012 Sep 26
18. González-Scarano F, Martín-García J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81
19. Grunwald IC, Korte M, Adelmann G, Plueck A, Kullander K, Adams RH et al (2004) Hippocampal plasticity requires postsynaptic ephrin Bs. Nat Neurosci 7:33-40
20. Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682-696
21. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, CHARTER Group; HNRC Group et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
22. Hruska M, Dalva MB (2012) Ephrin regulation of synapse formation, function and plasticity. Mol Cell Neurosci 50:35-44
23. Ivanov AI, Romanovsky AA (2006) Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life 58:389-394
24. Kaul M, Lipton SA (2006) Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1:138-151
25. Klein R (2001) Excitatory Eph receptors and adhesive ephrin ligands. Curr Opin Cell Biol 13:196-203
26. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res 14:1085-1094
27. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA (1992) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66:285-291
28. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M et al (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42:963-972
29. Mocchetti I, Bachis A, Masliah E (2008) Chemokine receptors and neurotrophic factors: potential therapy against aids dementia? J Neurosci Res 86:243-255
30. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, HNRC Group et al (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20:879-887
31. Murai KK, Pasquale EB (2011) Eph receptors and ephrins in neuron-astrocyte communication at synapses. Glia 59:1567-1578
32. Murai KK, Nguyen LN, Irie F, Yamaguchi Y, Pasquale EB (2003) Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci 6:153-160
33. Nolan T, Hands RE, Bustin SA (2006) Quantification of mRNA using real-time RT-PCR. Nat Protoc 1:1559-1582
34. Pasquale EB (2005) Eph receptor signaling casts a wide net on cell behavior. Nat Rev Mol Cell Biol 6:462-475
35. Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38-52
36. Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA (2012) α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. Brain Res 1459:71-80
37. Rose'Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR (2003) The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc 11:9-18
38. Sailasuta N, Shriner K, Ross B (2009) Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 22:326-331
39. Sheffler-Collins SI, Dalva MB (2012) EphBs: an integral link between synaptic function and synaptopathies. Trends Neurosci 35:293-304
40. Simón AM, de Maturana RL, Ricobaraza A, Escribano L, Schiapparelli L, Cuadrado-Tejedor M et al (2009) Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. J Alzheimers Dis 17:773-786
41. Sobel RA (2005) Ephrin A receptors and ligands in lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 15:35-45
42. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759-778
43. Wu J, Luo H (2005) Recent advances on T-cell regulation by receptor tyrosine kinases. Curr Opin Hematol 12:292-297
44. Yu G, Luo H, Wu Y, Wu J (2003) Ephrin B2 induces T cell costimulation. J Immunol 171:106-114
45. Yuferov V, Ji F, Nielsen DA, Levran O, Ho A, Morgello S, Shi R, Ott J, Kreek MJ (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34:1185-1197
46. Yuferov V, Nielsen DA, Levran O, Randesi M, Hamon S, Ho A, Morgello S, Kreek MJ (2011) Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs. Pharmacogenet Genomics 21:185-196